Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Squamous Cell Carcinoma of Head and Neck 11Nasopharyngeal Carcinoma 6Oropharyngeal Neoplasms 5Prostatic Neoplasms 4Laryngeal Neoplasms 4Carcinoma 4Mouth Neoplasms 3Hypopharyngeal Neoplasms 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Mesothelioma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Anus Neoplasms 2Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Mesothelioma, Malignant 1Meningioma 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Locally Advanced Cervical Adenocarcinoma 1HIV Infections 1Glioma 1Glioblastoma 1

Interventions

Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4Biopsy 3dehydroftorafur 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Proctoscopy 2Mitozytrex 2Mitomycin 2Fluorouracil 2Fluorodeoxyglucose F18 2Colonoscopy 2Capecitabine 2X-Rays 1Watchful Waiting 1Tomography, X-Ray Computed 1Taxes 1Surveys and Questionnaires 1Sentinel Lymph Node Biopsy 1Radionuclide Imaging 1Phantoms, Imaging 1Paclitaxel 1Observation 1Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin 1Magnetic Resonance Imaging 1Ipilimumab 1Ibuprofen 1Epinephrine 1Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anus Neoplasms × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT04166318 2026-05-05

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
252 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡